Dietmar Dammerer: How Should We Manage Traumatic Brain Injury When on Anticoagulants?
Dietmar Dammerer, Head of the Department of Orthopedics and Traumatology at the University Hospital Krems, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Archives of Orthopaedic and Trauma Surgery, adding:
”NEW PUBLICATION.
How should we manage patients with mild traumatic brain injury who are taking anticoagulants?
Despite the growing number of patients on antithrombotic therapy presenting to emergency departments after head trauma, clinical practice remains far from uniform.
I’m excited to share our newly published nationwide survey examining how Austrian trauma and neurosurgical departments manage patients with mild traumatic brain injury (mTBI) receiving antiplatelet agents, vitamin K antagonists, or direct oral anticoagulants.
Key findings:
- Nearly all participating departments routinely perform cranial CT scans in anticoagulated patients after mild head injury.
- Significant regional differences exist regarding hospital admission practices, particularly for patients receiving DOACs and those with hemophilia.
- Management strategies vary considerably across Austria, highlighting the absence of up-to-date national guidance.
As healthcare systems face increasing patient volumes and resource constraints, standardized, evidence-based protocols are becoming more important than ever.
Our findings underline a clear opportunity: developing contemporary national guidelines that support both patient safety and efficient resource utilization.
A sincere thank you to all participating departments and colleagues who contributed to this nationwide effort.
The full publication is now available, and I look forward to discussing its implications for trauma care, emergency medicine, neurosurgery, and healthcare policy.”
Title: Regional differences in the management of patients with mild traumatic brain injury and antithrombotic therapy—an Austrian survey
Authors: Barbara Sebek, Dietmar Dammerer, David Putzer, Lukas Moser

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026